Literature DB >> 11415458

Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data.

A Cortés1, M Cascante, M L Cárdenas, A Cornish-Bowden.   

Abstract

The concentration of an inhibitor that decreases the rate of an enzyme-catalysed reaction by 50%, symbolized i(0.5), is often used in pharmacological studies to characterize inhibitors. It can be estimated from the common inhibition plots used in biochemistry by means of the fact that the extrapolated inhibitor concentration at which the rate becomes infinite is equal to -i(0.5). This method is, in principle, more accurate than comparing the rates at various different inhibitor concentrations, and inferring the value of i(0.5) by interpolation. Its reciprocal, 1/i(0.5), is linearly dependent on v(0)/V, the uninhibited rate divided by the limiting rate, and the extrapolated value of v(0)/V at which 1/i(0.5) is zero allows the type of inhibition to be characterized: this value is 1 if the inhibition is strictly competitive; greater than 1 if the inhibition is mixed with a predominantly competitive component; infinite (i.e. 1/i(0.5) does not vary with v(0)/V) if the inhibition is pure non-competitive (i.e. mixed with competitive and uncompetitive components equal); negative if the inhibition is mixed with a predominantly uncompetitive component; and zero if it is strictly uncompetitive. The type of analysis proposed has been tested experimentally by examining inhibition of lactate dehydrogenase by oxalate (an uncompetitive inhibitor with respect to pyruvate) and oxamate (a competitive inhibitor with respect to pyruvate), and of cytosolic malate dehydrogenase by hydroxymalonate (a mixed inhibitor with respect to oxaloacetate). In all cases there is excellent agreement between theory and experiment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11415458      PMCID: PMC1221950          DOI: 10.1042/0264-6021:3570263

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor.

Authors:  P Y Law; O M Kouhen; J Solberg; W Wang; L J Erickson; H H Loh
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

2.  Nitric oxide inhibits isoproterenol-stimulated adipocyte lipolysis through oxidative inactivation of the beta-agonist.

Authors:  P Klatt; J Cacho; M D Crespo; E Herrera; P Ramos
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  A COMPARISON OF ESTIMATES OF MICHAELIS-MENTEN KINETIC CONSTANTS FROM VARIOUS LINEAR TRANSFORMATIONS.

Authors:  J E DOWD; D S RIGGS
Journal:  J Biol Chem       Date:  1965-02       Impact factor: 5.157

4.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

5.  CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

Authors:  L M Hesse; K Venkatakrishnan; M H Court; L L von Moltke; S X Duan; R I Shader; D J Greenblatt
Journal:  Drug Metab Dispos       Date:  2000-10       Impact factor: 3.922

6.  Antagonist inhibition curves and the measurement of dissociation constants.

Authors:  R B Barlow; S M Bond; E Bream; L Macfarlane; D S McQueen
Journal:  Br J Pharmacol       Date:  1997-01       Impact factor: 8.739

7.  Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.

Authors:  C Wandel; R B Kim; F P Guengerich; A J Wood
Journal:  Drug Metab Dispos       Date:  2000-08       Impact factor: 3.922

8.  O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.

Authors:  B T Zhu; U K Patel; M X Cai; A H Conney
Journal:  Drug Metab Dispos       Date:  2000-09       Impact factor: 3.922

9.  Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose.

Authors:  M A Moukil; M Veiga-da-Cunha; E Van Schaftingen
Journal:  Diabetes       Date:  2000-02       Impact factor: 9.461

10.  Charge balance in the alpha-hydroxyacid dehydrogenase vacuole: an acid test.

Authors:  A Cortes; D C Emery; D J Halsall; R M Jackson; A R Clarke; J J Holbrook
Journal:  Protein Sci       Date:  1992-07       Impact factor: 6.725

View more
  40 in total

1.  Binding of hematin by a new class of glutathione transferase from the blood-feeding parasitic nematode Haemonchus contortus.

Authors:  Arjan J van Rossum; James R Jefferies; Frans A M Rijsewijk; E James LaCourse; Paul Teesdale-Spittle; John Barrett; Andrew Tait; Peter M Brophy
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Active-learning exercises to teach drug-receptor interactions in a medicinal chemistry course.

Authors:  Seetharama D Satyanarayanajois
Journal:  Am J Pharm Educ       Date:  2010-10-11       Impact factor: 2.047

3.  Inhibition of Sodium-Hydrogen Antiport by Antibodies to NHA1 in Brush Border Membrane Vesicles from Whole Aedes aegypti Larvae.

Authors:  Kenneth M Sterling; William R Harvey
Journal:  J Membr Biol       Date:  2018-11-03       Impact factor: 1.843

4.  External mechanical force as an inhibition process in kinesin's motion.

Authors:  Aleix Ciudad; José María Sancho
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

5.  Synergy between verapamil and other multidrug -resistance modulators in model membranes.

Authors:  Madeleine Castaing; Alain Loiseau; Athel Cornish-Bowden
Journal:  J Biosci       Date:  2007-06       Impact factor: 1.826

6.  (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells.

Authors:  Keng Gat Lim; Chaode Sun; Robert Bittman; Nigel J Pyne; Susan Pyne
Journal:  Cell Signal       Date:  2011-05-18       Impact factor: 4.315

7.  How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?

Authors:  Angelo Spinello; Elena Vecile; Antonio Abbate; Aldo Dobrina; Alessandra Magistrato
Journal:  J Chem Inf Model       Date:  2019-01-10       Impact factor: 4.956

8.  Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).

Authors:  David J Merkler; Alexander S Asser; Laura E Baumgart; Natalie Carballo; Sarah E Carpenter; Geoffrey H Chew; Casey C Cosner; Jodi Dusi; Lamar C Galloway; Andrew B Lowe; Edward W Lowe; Lawrence King; Robert D Kendig; Paul C Kline; Robert Malka; Kathleen A Merkler; Neil R McIntyre; Mindy Romero; Benjamin J Wilcox; Terence C Owen
Journal:  Bioorg Med Chem       Date:  2008-10-11       Impact factor: 3.641

9.  Characterizing metabolic inhibition using electrochemical enzyme/DNA biosensors.

Authors:  Dominic O Hull; Besnik Bajrami; Ingela Jansson; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2009-01-15       Impact factor: 6.986

10.  Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis.

Authors:  Senem Aykul; Erik Martinez-Hackert
Journal:  Anal Biochem       Date:  2016-06-27       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.